Two Sigma Advisers’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-22,000
Closed -$143K 2725
2020
Q2
$143K Sell
22,000
-5,900
-21% -$38.1K ﹤0.01% 2310
2020
Q1
$184K Sell
27,900
-6,900
-20% -$60.1K ﹤0.01% 2190
2019
Q4
$361K Sell
34,800
-9,200
-21% -$78.7K ﹤0.01% 1999
2019
Q3
$278K Sell
44,000
-22,100
-33% -$165K ﹤0.01% 1946
2019
Q2
$492K Buy
66,100
+21,000
+47% +$139K ﹤0.01% 1822
2019
Q1
$277K Sell
45,100
-400
-0.9% -$4.63K ﹤0.01% 2012
2018
Q4
$524K Buy
45,500
+15,400
+51% +$263K ﹤0.01% 1750
2018
Q3
$652K Buy
30,100
+3,300
+12% +$62.4K ﹤0.01% 1695
2018
Q2
$423K Buy
26,800
+14,800
+123% +$233K ﹤0.01% 1984
2018
Q1
$226K Buy
+12,000
New +$237K ﹤0.01% 2110

Other funds holding ARA

Two Sigma Advisers's ARA Position: Q3 2020 in Review

Two Sigma Advisers sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2020, closing a stake of 22,000 shares — an estimated $143K sold.

Two Sigma Advisers first reported a position in ARA in Q1 2018 and held it in 10 quarters. The position peaked at $652K in Q3 2018. 56 funds tracked by Wall St. Rank hold ARA as of Q3 2020.

  • Two Sigma Advisers reported no remaining American Renal Associates Holdings, Inc position as of Q3 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 22,000 American Renal Associates Holdings, Inc shares in Q3 2020, an estimated $143K.
  • Two Sigma Advisers first reported a position in American Renal Associates Holdings, Inc in Q1 2018 and held it in 10 quarters.
  • Two Sigma Advisers's American Renal Associates Holdings, Inc position peaked at $652K in Q3 2018.
  • 56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2020.

Based on Two Sigma Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.